MANVILLE PERSONAL INJURY SETTLEMENT TRUST
Special-Purpose Unaudited Consolidated Financial Statements
For the Quarter Ended September 30, 2000
The consolidated financial statements included herein are unaudited. In the opinion of the management of the Trust, the accompanying consolidated financial statements present fairly, subject to normal year-end adjustments, the consolidated net claimants' equity as of September 30, 2000 and 1999 and the consolidated changes in net claimants' equity and cash flows for the three and nine months ended September 30, 2000 presented on the special-purpose basis of accounting described in Note 2, which accounting methods have been applied on a consistent basis.
/s/ Mark E. Lederer
Mark E. Lederer
Chief Financial Officer
MANVILLE PERSONAL INJURY SETTLEMENT TRUST
2000 |
1999 |
|
| ASSETS: | ||
| Cash equivalents and investments (Notes 1 & 2) | ||
| Available-for-sale non-JM | ||
| Restricted (Note 8) | $43,292,810 |
$49,572,826 |
| Unrestricted non-JM | 789,318,278 |
1,034,160,222 |
| Total | 832,611,088 |
1,083,733,048 |
| Other available-for-sale | ||
| JM common stock | 1,275,267,424 |
1,479,591,999 |
| Total cash equivalents and investments | 2,107,878,512 |
2,563,325,047 |
| Accrued interest and dividend receivables | 14,229,492 |
15,217,423 |
| Deposits and other assets | 181,831 |
151,618 |
| Total assets | 2,122,289,835 |
2,578,694,088 |
| LIABILITIES: | ||
| Accrued expenses | 5,489,478 |
5,314,188 |
| Unpaid claims (Notes 4, 6 & Exh. III) | ||
| Settled Pre-Class Action complaint | 1,370,673 |
1,839,995 |
| Outstanding Offers - Post Class Action complaint | 64,849,298 |
178,474,685 |
| Contribution and indemnity claims payable | ||
| (Notes 4, 8 and Exh. III) | 256,441 |
6,573,039 |
| Lease commitments payable (Note 5) | 2,045,258 |
2,699,761 |
| Total liabilities | 74,011,148 |
194,901,668 |
| NET CLAIMANTS' EQUITY (Note 6) | $2,048,278,687 |
$2,383,792,420 |
Three
Months |
Nine
Months |
|
| NET CLAIMANTS' EQUITY, | ||
| BEGINNING OF PERIOD | $2,329,952,803 |
$2,472,661,095 |
| ADDITIONS TO NET CLAIMANTS' EQUITY: | ||
| JM dividend (Notes 1 and 2) | 6,763,849 |
20,291,547 |
| Reimbursement by JM of prior years foreign income taxes | 108,666 |
|
| Non-JM investment income (Exh. I) | 23,070,577 |
58,929,321 |
| Net reduction in outstanding claim offers | 3,756,834 |
28,434,404 |
| Decrease in lease commitments payable | 148,791 |
506,461 |
| Total additions | 33,740,051 |
108,270,399 |
| DEDUCTIONS FROM NET CLAIMANTS' EQUITY: | ||
| Operating expenses (Exh. II) | 5,902,436 |
17,853,231 |
| Management expenses for investments in JM | 209,744 |
564,114 |
|
Net unrealized losses on non-JM available-for-sale securities |
|
|
| Claims settled | 55,995,685 |
187,198,105 |
| Unrealized loss of JM stock | 239,552,970 |
295,918,366 |
| Contribution and indemnity claim settled | 535,556 |
3,186,783 |
| Total deductions | 315,414,167 |
532,652,807 |
| NET CLAIMANTS' EQUITY, | ||
| END OF PERIOD | $2,048,278,687 |
$2,048,278,687 |
MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2000 AND 1999
Three
Months |
Nine
Months |
|
| CASH INFLOWS | ||
| JM dividends (Notes 1 and 2) | $6,763,849 |
$20,291,548 |
| Reimbursement by JM of prior years foreign income taxes | 108,666 |
|
| Investment receipts | 23,762,221 |
59,909,831 |
| Investment receipts on escrow accounts (Note 8) | 3,226 |
90,548 |
| Total cash inflows | 30,529,296 |
80,400,593 |
| CASH OUTFLOWS | ||
| Claim payments made | 56,045,685 |
187,350,105 |
| Contribution and indemnity claim payments | 535,556 |
9,651,727 |
| Total cash claim payments | 56,581,241 |
197,001,832 |
|
|
||
| Disbursements for Trust operating and asset | ||
| management expenses | 6,265,918 |
17,686,437 |
| Total cash outflows | 62,847,159 |
214,688,269 |
| NET CASH OUTFLOWS | (32,317,863) |
(134,287,676) |
| NON-CASH CHANGES | ||
| Net unrealized gains (losses) on non-JM | ||
| available-for-sale securities | (13,217,776) |
(27,932,208) |
| Change in deposits and other assets | 54,502 |
(193) |
| NET INCREASE (DECREASE) IN CASH EQUIVALENTS AND | ||
| NON-JM INVESTMENTS AVAILABLE-FOR-SALE | (45,481,137) |
(162,220,077) |
| CASH EQUIVALENTS AND NON-JM INVESTMENTS | ||
| AVAILABLE-FOR-SALE, BEGINNING OF PERIOD | 878,092,225 |
994,831,165 |
| CASH EQUIVALENTS AND NON-JM INVESTMENTS | ||
| AVAILABLE-FOR-SALE, END OF PERIOD | $832,611,088 | $832,611,088 |
The accompanying notes are an integral part of these statements.
MANVILLE
PERSONAL INJURY SETTLEMENT TRUST
(1) DESCRIPTION OF THE TRUST
The Manville Personal Injury Settlement Trust (the Trust), organized pursuant to the laws of the state of New York with its office in Katonah, New York, was established pursuant to the Manville Corporation (Manville) Second Amended and Restated Plan of Reorganization (the Plan). The Trust was formed to assume Manvilles liabilities resulting from pending and potential litigation involving (i) individuals exposed to asbestos who have manifested asbestos-related diseases or conditions, (ii) individuals exposed to asbestos who have not yet manifested asbestos-related diseases or conditions and (iii) third-party asbestos-related claims against Manville for indemnification or contribution. Upon consummation of the Plan, the Trust assumed liability for existing and future asbestos health claims. The Trust had initial funding and will receive ongoing fixed and contingent funding as described below under "Funding of the Trust." The Trusts funding is dedicated solely to the settlement of asbestos health claims and the related costs thereto, as defined in the Plan. The Trust was consummated on November 28, 1988.
In December 1998, the Trust formed a wholly-owned corporation, the Claims Resolution Management Corporation (CRMC), to provide the Trust with claim processing and settlement services. Prior to January 1, 1999, the Trust provided its own claim processing and settlement services. CRMC began operations on January 1, 1999 in Fairfax, Virginia. The accounts of the Trust and CRMC have been consolidated for financial reporting purposes. All significant balances and transactions between the Trust and CRMC have been eliminated in consolidation.
Funding of the Trust
The Trust was initially funded from the following sources:
Manville Stock Interests
On July 7, 1999 Johns Manville Corporation (JM) purchased approximately 12.2 million shares of its common stock from the Trust for approximately $166.8 million. Based on an agreement reached between the Trust and JM on June 7, 1999, the shares were purchased at the average closing price of $13.675, JMs common stock for the 20 business days beginning June 8, 1999 and ending July 6, 1999. After giving effect to the transaction, the Trust owns 112,730,819 shares of JM common stock or approximately 76% of outstanding shares.
On June 22, 2000, JM entered into a definitive merger agreement with an investor group led by affiliates of Hicks, Muse, Tate & Furst Inc. and Bears Stearns Merchant Fund Corp. Under the terms of the agreement, JMs public shareholders (including the Trust) will receive, for each share of JM stock held, $13.625 in cash and 13 percent pay-in-kind preferred stock (PIK Preferred). However, as a condition of the transaction, the Trust is obligated to re-invest $50 million in the new common equity and equivalents of the post-merger company. Therefore, based on the 112,730,819 shares of JM common stock held by the Trust, the Trust will receive approximately $1.5 billion in cash and about $219 million in liquidation preference of PIK Preferred stock along with approximately 8.4 percent of the ongoing companys common stock and equivalents. In addition, contingent upon the transaction, JM has agreed to pay the Trust $90 million in settlement of JMs obligation for future income taxes of the Trust. The transaction is expected to close at the end of the year, subject to various conditions, including receipt of financing, bankruptcy court, shareholder and regulatory approvals. Transaction costs for legal and investment banking will be netted against the proceeds received assuming the transactions is consummated.
In connection with the merger agreement, the Trust entered into a voting agreement with the company merging with and into JM. Pursuant to this voting agreement, the Trust agreed that, except under certain circumstances, it will vote all its shares of JM stock in favor of the merger and not offer for sale, sell or otherwise dispose of its JM stock, except as contemplated in the merger transaction.
On October 19, 2000, JM announced it did not believe that the transaction will be completed on the terms contained in the previously announced definitive merger agreement with the investor group and that JM was currently engaged in discussions with the investor group regarding possible changes in the transaction. The Trust also believes the transaction will not be completed on the previously agreed to terms and the Trust is participating in discussions with the investor group.
(2) SIGNIFICANT ACCOUNTING POLICIES
(a) Basis of Presentation
The Trusts financial statements are prepared using special-purpose accounting methods that differ from generally accepted accounting principles (GAAP). The special-purpose accounting methods were adopted in order to better communicate to the beneficiaries of the Trust the amount of equity available for payment of current and future claims. These special-purpose accounting methods are enumerated as follows:
1. The financial statements are prepared using the accrual basis of accounting.
2. The funding received from JM and its liability insurers has been
recorded directly to net claimants
equity. These funds do not represent income of
the Trust. Settlement offers for asbestos health
claims are reported as deductions in net
claimants equity and do not represent expenses of the
Trust.
3. Costs of non-income producing assets, which will be exhausted
during the life of the Trust and
are not available for satisfying claims, are expensed
as they are incurred. These costs include
acquisition costs of computer hardware, software,
software development, office furniture and
leasehold improvements.
4. Future fixed liabilities and contractual obligations entered into
by the Trust are recorded directly
against net claimants equity. Accordingly, the
future minimum rental commitments outstanding
at period end for non-cancelable operating leases,
net of any sublease agreements, have been
recorded as deductions to net claimants equity.
5. The liability for unpaid claims reflected in the statements of net
claimants equity represents settled
but unpaid claims and outstanding settlement
offers. Post-Class Action complaint claims liability
is recorded once a settlement offer is made to
the claimant (Note 4) at the amount equal to the
expected pro rata payment. No liability is
recorded for future claim filings and filed claims on
which no settlement offer has been made. Net
claimants equity represents funding available to
pay present and future claims on which no fixed
liability has been recorded.
6. Available-for-sale securities are recorded at market.
Held-to-maturity securities are recorded at
amortized cost. All interest and dividend income, as
well as net realized gains/losses, on non-JM
available-for-sale securities are included in non-JM
investment income on the statements of changes
in net claimants equity. Realized gains on JM
common stock and unrealized gains and losses on
non-JM available-for-sale securities are recorded as
separate components on the statements of
changes in net claimants equity.
The preparation of financial statements in conformity with the
special-purpose accounting methods
described above requires management to make estimates and assumptions that affect the
reported
amounts of assets and liabilities at the date of the financial statements and the reported
amounts of
additions and deductions to net claimants equity during the reporting period. Actual
results could
differ from those estimates. The most significant estimates with regard to these financial
statements
relate to unpaid claims, as discussed in Notes 4 and 6.
(b) JM Common Stock Interest
The Trusts stock interests represent a majority stock interest in
JM. The accounts of JM have not
been consolidated in the accompanying financial statements because: (i) JM stock interests
are held
by the Trust in order to pay asbestos health claims, and as such, the investment is likely
to be
temporary; and (ii) the objective of the financial statements is to communicate the equity
available
over the life of the Trust to current and future claimants. Thus, the Trust believes that
recording
these stock interests at current market value is appropriate.
At consummation, the Trusts stock interests were recorded at market value. Subsequent changes in their market values are shown separately as unrealized appreciation/depreciation in the carrying value of JM common stock in the statements of changes in net claimants equity. The market value of the JM common stock held by the Trust is recorded by using the closing price of JM common stock on the New York Stock Exchange composite transactions on the last day of the appropriate reporting period. As of September 30, 2000 and 1999, that price was $11.3125 and $13.125 per share, respectively. Nevertheless, the Trust may not realize this value as a result of potential illiquidity in the public sale of a major position in JM common stock without disruption to the public market. Further, any premium that might be obtained upon a private sale of a controlling interest in JM may also impact this value.
(c) Trust Second Bond
On June 30, 1999 JM prepaid the Trust Second Bond resulting in the payment to the Trust of $33,215,716, using an agreed-upon discount rate of 10.6% as part of the June 7, 1999 agreement between the Trust and JM (Note 1).
(d) Cash Equivalents and Non-JM Investments
At September 30, 2000 and 1999 the Trust has recorded all its non-JM investment securities at market value, as follow
| 2000 1999 | ||||
| Cost | Market | Cost | Market | |
| Restricted | ||||
| Cash equivalents | $453,367 | $453,367 | $3,249,633 | $3,249,633 |
| U.S. Govt. oblig. | 11,504,440 | 11,462,278 | 12,611,611 | 12,488,721 |
| Corporate and other debt | 4,415,162 | 7,413,496 | 4,387,451 | 4,347,221 |
| Equities - U.S. | 13,716,258 | 23,963,669 | 23,591,671 | 29,487,251 |
Total |
$33,089,227 | $43,292,810 | $43,840,366 | $49,572,826 |
| Unrestricted | ||||
| Cash equivalents | $87,944,784 |
$87,944,784 | $324,670,649 |
$324,670,649 |
| U.S. govt. obligations | 201,661,231 | 201,704,190 | 195,933,959 |
191,482,268 |
| Foreign govt. obligations | 94,835,796 | 92,241,334 | 104,933,111 | 103,524,003 |
| Corporate and other debt | 218,021,418 | 214,469,092 | 212,913,720 | 207,704,097 |
| Equities - U.S. | 76,289,762 | 120,058,519 | 89,639,524 | 131,244,365 |
| Equities - International | 60,964,082 | 72,900,359 | 59,073,183 | 75,534,840 |
| Total | $739,717,073 | $789,318,278 | $987,164,146 | $1,034,160,222 |
Less Than |
After 1 Year |
After 5 Years |
After 10 Yrs |
|
| U.S. govt. obligations | $5,655,989 | $46,741,358 | $40,062,927 | $120,706,193 |
| Foreign govt. obligations | 7,998,145 | 38,661,057 | 24,404,610 | 21,177,522 |
| Corporate and other debt | 17,377,319 | 139,871,447 | 31,689,516 | 32,944,306 |
| Total | $31,031,453 | $225,273,862 | $96,157,053 | $174,828,021 |
The Trust invests in two types of derivative financial instruments. Equity index
futures are used as
strategic substitutions to cost effectively replicate the underlying index of its domestic
equity
investment fund. At September 30, 2000, the fair value of these instruments was
approximately
$1.4 million and was included in non-JM investments available-for-sale on the statement of
net
claimants equity. Foreign currency forwards are utilized for both currency
translation purposes
and to hedge against the currency risk inherent in foreign bond issues. At September 30,
2000,
the Trust held at market value approximately $137.2 million in sell currency forward
contracts
offset by approximately $135.3 million in buy currency forward contracts. The unrealized
gains
on these outstanding currency forward contracts of approximately $1.9 million is
principally offset
by corresponding unrealized losses due to currency exchange on the underlying securities
being
hedged. These amounts are recorded in the statement of net claimants equity at
September 30, 2000.
(e) Fixed Assets
The cost of non-income producing assets that will be exhausted
during the life of the Trust and are
not available for satisfying claims are expensed as incurred. Since inception, these
costs, net of
disposals, include:
Acquisition of furniture and equipment
$ 757,371
Acquisition of computer
hardware and software
1,524,588
Leasehold improvements
42,965
Total
$2,324,924
These items have not been recorded as assets, but rather as direct deductions to net
claimants equity in
the accompanying financial statements. The cost of fixed assets, net of proceeds on
disposals, that were
expensed during the three months and nine months ended September 30, 2000 was
approximately
$10,448 and $106,300 respectively.
Depreciation expense related to asset acquisitions using generally
accepted accounting principles
would have been approximately $54,600 and $162,800 for the three months and nine months
ended September 30, 2000, respectively.
(f) JM Dividends
Beginning in August 1996, the JM Board of Directors declared
regular quarterly dividends of $.03
per share, the first time such dividends were declared since 1982. In August 1997 the
dividend was
increased to $.04 per share and in August 1998 to $.06 per share. Such dividends are
reported as
additions to net claimants equity.
(3) LITIGATION
During 1997 the Trust filed a complaint in the U.S. District Court for
the Eastern District of New York
(the Court) on behalf of the Trustees against seven tobacco manufacturers ("Falise
I"), pursuant to which
the Trust sought contribution and indemnification for claims paid and to be paid in which
a portion of
the claimants injury was caused by smoking. In November 1999, the Court dismissed
Falise I on
jurisdictional grounds and during the same month, the Trust filed a second complaint
("Falise II")
which alleged the same causes of action as in Falise I and, in addition, violations of the
Federal
RICO Act. Pursuant to an order of the Court, all discovery taken by both sides in Falise I
are
considered to be a part of Falise II. A trial date in Falise II is scheduled to November
27, 2000.
(4) UNPAID CLAIMS
The Trust distinguishes between claims that were resolved prior to the
filing of the class action
complaint on November 19, 1990 and claims resolved after the filing of that complaint.
Claims resolved
prior to the complaint (Pre-Class Action Claims) were resolved under various payment
plans, all of
which called for 100% payment of the full liquidated amount without interest over some
period of time.
However, between July 1990 and February 1995, payments on all claims except qualified
exigent
health and hardship claims were stayed by the courts. By court order on July 22, 1993
(which
became final on January 11, 1994), a plan submitted by the Trust was approved to
immediately pay,
subject to claimant approval, a discounted amount on Pre-Class Action Claims, in full
satisfaction of
these claims. The discount amount taken, based on the claimants who accepted the
Trusts discounted
offer, was approximately $135 million.
The unpaid liability for the Post-Class Action claims represents
outstanding offers made in First-in,
First-out (FIFO) order to claimants eligible for settlement after November 19, 1990. Under
the TDP
(Note 6), claimants receive an initial pro rata payment equal to 10% of the liquidated
value of their
claim. The Trust remains liable for the unpaid portion of the liquidated amount only to
the extent that
assets will be available after paying all claimants the established pro rata share of
their claims. The
Trust makes these offers in the form of a check made payable to the claimant and/or
claimants
counsel. If the offer is accepted, the check is deposited, a Trust release is completed
and the claim
is recorded as settled. An unpaid claim liability is recorded once an offer is made. The
unpaid claim
liability remains on the Trusts books until accepted or expiration of the offer
after 180 days. A
claimant may request that an offer be extended for an additional 180 days.
Pursuant to the Stipulation of Settlement, the Trust is obligated to
pay approximately $63 million plus
investment earnings on funds set aside for contribution and indemnity claims occurring
before
July 25, 1994. As of September 30, 2000, approximately $256,000 remains to be paid.
(5) COMMITMENTS AND CONTINGENCIES
Operating Leases
In September 1993, the Trust executed a 5-year lease through December
1998 for its offices in
Fairfax, Virginia. The lease was extended for an additional 5 years beginning at the
expiration of the
initial lease. Effective January 1, 1999, the Trust assigned its rights under the lease to
CRMC
conditioned upon the Trusts guarantee of future lease payments.
Future minimum rental commitments under this operating lease, as of September 30, 2000 are as follows:
Calendar Year Amount
2000
$148,787
2001
613,122
2002
631,969
2003
651,381
Total $2,045,258
This obligation has been recorded as a liability at face value in the accompanying financial statements.
(6) NET CLAIMANTS EQUITY
A class action complaint was filed on behalf of all Trust beneficiaries
on November 19, 1990, seeking to
restructure the methods by which the Trust administers and pays claims. On July 25, 1994,
the parties
signed a Stipulation of Settlement that included a revised Trust Distribution Process (the
TDP).
The TDP prescribes certain procedures for distributing the Trusts limited assets,
including pro rata
payments and initial determination of claim value based on scheduled diseases and values.
The
Court approved the settlement in an order dated January 19, 1995. Though six appeals were
filed
with the Court of Appeals, no stay was granted and the Trust implemented the TDP payment
procedures effective February 21, 1995. On February 21, 1996, the Court of Appeals
affirmed
the decision.
Prior to the commencement of the class action in 1990, the Trust filed
a motion for a determination
that its assets constitute a "limited fund" for purposes of Federal Rules of
Civil Procedure 23(b)(1)(B).
The Courts adopted the findings of the Special Master that the Trust is a "limited
fund". In part,
the limited fund finding concludes that there is a substantial probability that estimated
future assets
of the Trust are and will be insufficient to pay in full all claims that have been and
will be asserted
against the Trust.
The TDP contains certain procedures for the distribution of the
Trusts limited assets. Under the TDP,
the Trust forecasts its anticipated annual sources and uses of cash until the last
projected future claim
has been paid. A pro rata payment percentage is calculated such that the Trust will have
no remaining
assets or liabilities after the last future claimant receives his/her pro rata share.
The Trust has conducted its own research and monitored studies prepared
by the Courts appointee
regarding the valuation of Trust assets and liabilities. Based on this valuation, the TDP
provides for
an initial 10% payment of the liquidated value of current and future claims. Accordingly,
the Trust
has reported Post-Class Action Claims at 10% of their liquidated value. The 10% pro rata
payment
represents the Trusts best estimate of funds available over the life of the Trust to
pay claims settled
under the TDP. The Trust will continue to monitor this estimate based on changes in
settlement practices
and changes in future projected values of Trust assets and liabilities and make any
necessary changes
in the pro rata payment percentage as required under the TDP.
(7) EMPLOYEE BENEFIT PLANS
The Trust established a tax-deferred employee savings plan under
Section 401(k) of the Internal
Revenue Code, with an effective date of January 1, 1988. The plan allows employees to
defer a
percentage of their salaries within limits set by the Internal Revenue Code with the Trust
matching
contributions by employees of up to 6% of their salaries. The total employer contributions
and
expenses under the plan were approximately $69,500 and $211,800 for the three months and
nine months ended September 30, 2000.
(8) RESTRICTED ASSETS
In order to avoid the high costs of director and officer liability
insurance and with the approval
of the United States Bankruptcy Court for the Southern District of New York, the Trust
established
a segregated security fund of $30,000,000 and, with the additional approval of the United
States
District Court for the Southern and Eastern Districts of New York, an escrow fund of
$3,000,000
from the assets of the Trust, which are devoted exclusively to securing the obligations of
the
Trust to indemnify the former and current Trustees and officers, employees, agents and
representatives
of the Trust. In addition, a $15,000,000 escrow and security fund was established to
secure the
obligations of the Trust to exclusively indemnify the current Trustees, whose access to
the other
security funds is subordinated to the former Trustees. Upon the final order in the Class
Action
litigation (Note 4), the $15,000,000 escrow and security fund was reduced by $5,000,000.
Pursuant to Section 5.07 of the plan, Trustees are entitled to a lien on the segregated
security
and escrow funds to secure the payment of any amounts payable to them through such
indemnification.
Accordingly, in total $43 million has been transferred from the Trusts bank accounts
to separate
escrow accounts and pledge and security agreements have been executed perfecting those
interests.
The investment earnings on these escrow accounts accrue to the benefit of the Trust and
are
recorded as unrestricted investments.
Pursuant to the Stipulation of Settlement, the Trust funded separate
investment accounts for two
of the sub-class beneficiaries. During 1996, one of these accounts was fully disbursed and
the
remaining balance for the other account at September 30, 2000 is $0.29 million. This
balance
and the $43 million of self-insurance funds described above, have been reported as
restricted
investments.
(9) INCOME TAXES
For Federal income tax purposes, JM has elected for the qualified
assets of the Trust to be taxed as a
Designated Settlement Fund (DSF). Income and expenses associated with the DSF are taxed in
accordance with Section 468B of the Internal Revenue Code, which obligates JM to pay for
any
federal income tax liability imposed upon the DSF. In addition, pursuant to an agreement
between
JM and the Trust, JM is obligated to pay for any income tax liability. Accordingly, no
liability or
income tax provision has been recorded for the Trust. However, contingent upon
consummation
of the merger transaction, JM will pay the Trust $90 million. In return, the Trust will
terminate
JMs contractual liability for income taxes of the Trust and agree to indemnify JM in
respect for
all future income taxes of the Trust.
JM however, is not obligated to pay the federal and state income taxes
of CRMC and the provision for
income taxes on Exhibit II is the responsibility of CRMC. The Trust accounts for
CRMCs income
taxes in accordance with the Statement of Financial Accounting (SFAS) No. 109,
"Accounting for
Income Taxes." SFAS No. 109 requires the recognition of deferred tax assets and
liabilities for the
expected future tax consequences of temporary differences between the book and tax basis
of assets
and liabilities. As of September 30, 2000, the Trust has recorded a net deferred tax asset
of $32,000,
representing temporary timing differences primarily for CRMCs accrued vacation and
deferred
compensation. The deferred asset is included in deposits and other assets in the
accompanying
consolidated statement of net claimants equity.
The income and expenses attributable to Trust assets not in the DSF are
taxed as if these assets
were in a "Grantor Trust." Consequently, income and expenses associated with
these assets are
included in the income tax return of JM (the Grantor) and are not part of the DSF.
(10) PROOF OF CLAIMS FILED
Proof of claim forms have been filed with the Trust as follows:
As of |
As of |
|
| Claims filed | 467,963 |
419,509 |
| Voided claims (1) | (37,290) |
(36,351) |
| Currently disqualified (2) | (1,419) |
(1,080) |
| Expired offers (3) | (39,921) |
(30,556) |
| Active claims | 389,333 |
351,522 |
| Settled claims | (323,654) |
(240,923) |
| Claims currently eligible for settlement | 65,679 |
110,599 |
(1)
Claim filings that are permanently ineligible due to duplication of filing, withdrawal or missing(2)
Claim filings on hold until representation or content problems are resolved.(3)
Claims that received a Trust offer, but failed to respond within the offer acceptance period.EXHIBIT I
|
|
|
| NON-JM INVESTMENT INCOME | ||
| Interest | $9,712,610 |
$29,717,703 |
| Dividends | 745,959 |
2,677,519 |
| Net realized gains | 13,079,464 |
27,688,218 |
| Total non-JM investment income | 23,538,033 |
60,083,440 |
| Investment expenses | (467,456) |
(1,154,119) |
| TOTAL | $23,070,577 |
$58,929,321 |
MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED OPERATING EXPENSES
FOR THE THREE AND NINE MONTHS ENDED SEPTEBMER 30, 2000
Three
Months |
Nine
Months |
|
| OPERATING EXPENSES: | ||
| Personnel costs | $1,470,910 |
$4,659,198 |
| Office general and administrative | 290,022 |
992,238 |
| Travel and meetings | 89,880 |
280,322 |
| Board of Trustees | 144,373 |
413,521 |
| Professional fees | 3,912,883 |
11,265,112 |
| Net fixed asset purchases | 10,448 |
106,300 |
| Computer and other EDP costs | 27,911 |
72,989 |
| Dispute resolution expenses | 13,709 |
20,351 |
| CRMC income taxes (benefits) | (57,700) |
43,200 |
TOTAL OPERATING EXPENSES |
$5,902,436 |
$17,853,231 |
The accompanying notes are an integral part of this exhibit.
MANVILLE PERSONAL INJURY SETTLEMENT TRUST
SCHEDULE OF LIQUIDATED CLAIMS
SINCE CONSUMMATION (NOVEMBER 28, 1988)
THROUGH SEPTEMBER 30, 2000
|
|
Average |
||||
| Trust Liquidated Claims | ||||||
| Pre-Class Action Complaint | ||||||
| November 19, 1990 and Before- | ||||||
| Liquidated Claim Value | 27,610 |
$1,188,264,972 |
||||
| Present Value Discount (1) | ______ |
(135,306,535) |
||||
| Net Settlements | 27,610 |
1,052,958,437 |
||||
| Payments | (27,550) |
(1,051,587,764) |
$38,170 | |||
| Unpaid Balance | 60 |
$1,370,673 |
||||
| Post-Class Action Complaint | ||||||
| After November 19, 1990- | ||||||
| Offers Made at Full Liquidated Amount | 314,288 |
$13,594,048,580 |
||||
| Reduction in Claim Value (2) | ______ |
(12,234,365,757) |
||||
| Net Offer Amount | 314,288 |
1,359,682,823 |
||||
| Payments | (296,044) |
(1,294,833,525) |
$4,374 | |||
| Offers Outstanding | 18,244 |
$64,849,298 |
||||
| Manville Liquidated Claims (3) | ||||||
| Liquidated Claim Value | 158 |
$24,946,620 |
||||
| Payments | (158) |
(24,946,620) |
||||
| Unpaid Balance | 0 |
$0 |
||||
| Co-Defendant Liquidated Claims (4) | ||||||
| Liquidated Claim Value | $90,990,801 |
|||||
| Investment Receipts (5) | 2,603,520 |
|||||
| Payments | (93,337,880) |
|||||
| Unpaid Balance | $256,441 |
|||||
(1) The unpaid liability for
Pre-Class Action Complaint claims has been reduced based upon a plan approved by the
Courts in
January, 1994 which requires the Trust to offer
to pay a discounted amount in full satisfaction of the unpaid claim amount.
(2) Under the TDP, Post Class Action Complaint claims have been reported at 10% of their liquidated value.
(3) Manville Liquidated
Claims refers to Liquidated AH Claims (as defined in the Plan) which the Trust has paid or
accrued as
payable pursuant to an order of the
United States Bankruptcy Court for the Southern District of New York dated January
27, 1987.
(4) Number of personal injury claimants not identifiable.
(5) Investment receipts of
separate investment escrow account established for the sub-class beneficiaries per the
Stipulation of
Settlement, net of income taxes.
The accompanying notes are an integral part of this exhibit.
MANVILLE PERSONAL INJURY SETTLEMENT TRUST
SCHEDULE OF LIQUIDATED CLAIMS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2000
|
|
Average |
|||
| Trust Liquidated Claims | |||||
| Pre-Class Action Complaint | |||||
| November 19, 1990 and Before- | |||||
| Payable as of June 30, 2000 | 61 |
$1,420,673 |
|||
| Rejected settlement | |||||
| Present Value Discount | |||||
| Paid (1) | 1 |
(50,000) |
|||
| Payable as of September 30, 2000 | 60 |
$1,370,673 |
|||
| Post-Class Action Complaint | |||||
| After November 19, 1990- (2) | |||||
| Offers Outstanding as of June 30, 2000 | 21,325 |
$68,606,132 |
|||
| Net Offers Made (3) | 10,803 |
52,238,851 |
|||
| Offers Accepted | (13,884) |
(55,995,685) |
$4,033 |
||
| Offers Outstanding as of September 30, 2000 | 18,244 |
$64,849,298 |
|||
| Co-Defendant Liquidated Claims | |||||
| Payable as of June 30, 2000 | $253,215 |
||||
| Settled | 535,556 | ||||
| Investment Receipts (4) | 3,226 | ||||
| Paid | (535,556) | ||||
| Payable as of September 30, 2000 | $256,441 |
||||
(2) Under the TDP, Post
Class Action Complaint claims have been reported at 10% of their liquidated value.
(3) Represents payment offers made during the period net of rejected and
expired offers.
(4) Investment receipts of
separate investment escrow account established for the sub-class beneficiaries per the
Stipulation of Settlement, net of income taxes.